https://www.selleckchem.com/pr....oducts/halofuginone.
riate provision of routine medication and management of medical co-morbidity are needed to promote fast recovery.There are widespread anecdotal reports of seemingly successful treatment among the early (three to seven days from symptoms) stage coronavirus disease 2019 (COVID-19) patients with the drug hydroxychloroquine (HCQ), and randomized placebo-controlled trials of HCQ in outpatient settings are underway. In this note, we (1) report observational evidence and present scientific reasoning as to why early treatment with HCQ may
Like
Comment
Share
